Journal of the American Society of Hypertension
Volume 1, Issue 6 , Pages 373-380, November 2007

Historical perspective of low- vs. high-dose diuretics

  • Barry J. Materson, MD, MBA

      Affiliations

    • Corresponding Author InformationCorresponding author: Barry J. Materson, MD, MBA, University of Miami Miller School of Medicine, OPPRP (D-54), P.O. Box 016960, Miami, Florida 33101. Tel: 350-243-7221; fax: 305-243-9902.

Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA

Received 5 June 2007; accepted 21 June 2007.

Abstract 

In the 50 years since the introduction of cholorothiazide by Fries and Wilson for the treatment of hypertension, numerous thiazide and thiazide-like diuretics have been marketed. Orally-administered diuretics enhanced the therapeutic efficacy of extant antihypertensive medications and reduced the doses required; adverse effects were thereby reduced as well. Initially, high doses of diuretics were employed at least in part because of the misconception that substantial natriuresis was required for their antihypertensive effect. As the long-term vasodilating effects of the thiazides became appreciated, it was possible to separate antihypertensive dose-response from natriuretic dose-response. As ever lower doses of thiazides were proven to be effective, most of their associated biochemical side and adverse effects were also reduced. Fifty years later, thiazide diuretics maintain a key role in the treatment of hypertension-especially in combination with one or more non-diuretic drugs.

Keywords: Thiazide, hypertension, inulin, diuretics

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: none.

PII: S1933-1711(07)00150-7

doi:10.1016/j.jash.2007.06.007

Journal of the American Society of Hypertension
Volume 1, Issue 6 , Pages 373-380, November 2007